S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

DSGN Design Therapeutics Inc

6.155

0.00 (0.00%)

Pre Market

Last Updated: 21:23:00

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Design Therapeutics (NASDAQ:DSGN)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Design Therapeutics Charts.

Design Therapeutics (NASDAQ:DSGN)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Design Therapeutics Charts.

Design Therapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Friday 20 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Design Therapeutics to Participate in Multiple Upcoming Investor Conferences
Thursday 14 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Design Therapeutics Announces Third Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTACTM Portfolio
Friday 8 November 2024 (2 months ago) • GlobeNewswire Inc.

Design Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference
Tuesday 10 September 2024 (4 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 13 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Saturday 10 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 5 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 5 August 2024 (5 months ago) • Edgar (US Regulatory)

Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTAC™ Portfolio
Monday 5 August 2024 (5 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 18 June 2024 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 18 June 2024 (7 months ago) • Edgar (US Regulatory)

More Design Therapeutics Inc News Articles

SPDR S&P Euro Dividend A...

State Street Global Advi...

Societe Generale Effekten

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions